gp41 gene therapy (Genetic Therapy)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namegp41 gene therapy (Genetic Therapy)
Drug Alias NameP17 gene therapy (Genetic Therapy)
ClassificationBiologics
Mechanisms of ActionHIV p17 matrix protein modulatorsTransmembrane glycoprotein gp41 modulators
TargetsTransmembrane glycoprotein gp41HIV p17 matrix protein
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenetic Therapy Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenetic Therapy Inc
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A